Efficacy and Safety of the Regulatory Polypeptides in Patients With Peripheral Atherosclerosis.
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT05933720
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 120 participants
- Sponsor
- Ryazan State Medical University
- Registry
-
NCT05933720
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Russia
- Registry status
- Unknown status
Technical summary
Registry record NCT05933720. Non-randomized; no masking; primary purpose treatment. Start 2023-04-01 (actual); primary completion 2026-06-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of the Regulatory Polypeptides in Patients With Peripheral Atherosclerosis.
- Condition
- Peripheral Arterial Occlusive Disease
- Intervention (Drug)
- Polypeptides
- Intervention (Device)
- Femoral-popliteal bypass grafting with a synthetic graft above the knee
- Intervention (Other)
- Routine conservative treatment
- Lead sponsor
- Ryazan State Medical University
Record details
- Record id
cardio:ct-nct05933720- Content hash
c41e7e82453fd6642fb10160f9ceb0af6a29d1ff3f5a8674057a27dcc27fc326